Navigation Links
Common Painkillers Might Boost Odds for 2nd Heart Attack

By Steven Reinberg
HealthDay Reporter

MONDAY, Sept. 10 (HealthDay News) -- People who've already suffered a heart attack may face higher odds of death or subsequent heart attack if they regularly take a common form of painkiller, Danish researchers report.

The painkillers are known as nonsteroidal anti-inflammatory drugs (NSAIDs), and include over-the-counter drugs such as ibuprofen (Advil, Motrin) and naproxen (Aleve), as well as prescription drugs such as Celebrex (celecoxib), the researchers noted.

"These results support previous findings that NSAIDs have no apparent safe treatment window among patients with a [prior] heart attack," said lead researcher Dr. Anne-Marie Schjerning Olsen from the department of cardiology at the University of Copenhagen. "Long-term caution with use of NSAIDs is advised in all patients after a heart attack," she said.

Olsen added that "it is important to get the message out to clinicians taking care of patients with cardiovascular disease that NSAIDs are harmful, even several years after a heart attack."

The report was published in the Sept. 10 issue of Circulation.

For the study, researchers collected data on almost 100,000 people who had experienced a heart attack between 1997 and 2009. They found that 44 percent of these patients had filled at least one prescription for an NSAID.

Compared to non-users, people who took the painkillers had a 59 percent higher risk of dying from any cause within a year after their heart attack, and a 63 percent higher risk within five years, the researchers found.

In addition, the risk of having another heart attack or dying from heart disease increased 30 percent within one year, and 41 percent after five years, the Danish team said.

These findings were the same for men and women regardless of age and income, the researchers found, and the study also accounted for factors such as other illnesses or medications.

Still, the data comes from what's known as an observational study, so it cannot prove that NSAIDs helped cause the deaths and heart attacks -- only that there was an association.

Nevertheless, the use of these drugs should be limited and the ability to buy them over-the-counter should be reconsidered, the researchers concluded.

"It has been shown in multiple prior studies that regular use of NSAIDs, including those that are available over the counter, is associated with increased risk of cardiovascular events," noted Dr. Gregg Fonarow, a spokesman for the American Heart Association and a professor of cardiology at the University of California, Los Angeles, who was not involved with the study.

"Even short-term use in patients after a heart attack or with heart failure has been associated with excess risk," he said.

Since 2007, American Heart Association guidelines have warned of the potential cardiovascular risk of NSAIDs in patients with established cardiovascular disease and after a heart attack and discouraged their use in these patients, Fonarow noted.

"This study highlights that substantial caution is necessary when considering NSAIDs in patients after a heart attack no matter how long ago the heart attack occurred," he said.

"Patients with a history [of heart attack] should consult with their physicians before taking NSAIDs, including those that are available over the counter," Fonarow added.

After a heart attack patients are usually prescribed aspirin, which is also an NSAID. However, "these findings do not apply to aspirin, which is a protective therapy after a heart attack," Fonarow stressed.

More information

For more information on heart attack, visit the American Heart Association.

SOURCES: Anne-Marie Schjerning Olsen, M.D., department of cardiology, University of Copenhagen, Denmark; Gregg Fonarow, M.D., spokesman, American Heart Association, and professor, cardiology, University of California, Los Angeles; Sept. 10, 2012, Circulation

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Texting in College Classrooms Common, Distracting
2. Recovery from propofol anesthesia may be sped by use of common stimulant
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Overuse Injuries Common Among Female College Athletes
5. Common Blood Pressure Drug Safe for Heart Failure: Study
6. Test links strains of common parasite to severe illness in US newborns
7. Common Plastics Chemical Might Boost Diabetes Risk
8. Off-Label Drug Use Appears Common
9. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
10. Slow-growing babies more likely in normal-weight women; Less common in obese pregnancies
11. Common Blood Pressure Drugs May Not Cut Colon Cancer Risk
Post Your Comments:
Related Image:
Common Painkillers Might Boost Odds for 2nd Heart Attack
(Date:10/13/2017)... , ... October 13, 2017 , ... ... serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing an ... to overcome a rare and deadly chromosome abnormality. , After struggling since birth ...
(Date:10/13/2017)... ... 2017 , ... As health professionals work to improve their approach to healthcare, ... doing more than filling out a survey; in many cases health professionals and patients ... health care and research on the importance of active engagement with patients and members ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected ... Dr. James C. Puffer upon his retirement. Dr. Newton will serve in the position ... the end of 2018. Upon assuming the role of President and CEO on January ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/10/2017)... received FDA 510(k) clearance in May 2017 for its highly anticipated ... for endoscopy environments. An innovative secondary monitor solution, ZeroWire Mobile ... the improvement of patient outcomes, procedural efficiency, and the lowering of ... ... By ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology: